Training Opportunities to Leverage the CTN Network (recording) |
|
 This presentation for the NIDA CTN Steering Committee Meeting held on September 18, 2023, featured Aria Crump, ScD, Deputy Director of the NIDA Office of Research, Training, Diversity and Disparities and Director of the NIDA Office of Diversity and Disparities.
This 35-minute presentation provides information about different types of funding available through NIDA, focusing on career development and workforce diversity. Dr. Crump reviewed a range of different types of NIDA awards, including R, T, and K awards, HEAL Initiative awards, and unique programs like NIDA’s Loan Repayment Program, which helps early career investigators, especially those from underrepresented backgrounds, repay their student loans.
She also demonstrated how to use the NIH RePORTER to find information about active awards and talked about NIH’s ongoing commitment to diversity and dedication to supporting early career investigators and other scientists from a range of backgrounds and specialties.
Check out the recording here!
· · · · · · · · · · · · · · · · · · · · · · · · · · · · ·
· · · · · · · · · · · · · · ·
REMINDER: Subscribe to the CTN Library's What's New Blog to Get Events, Publications, and More Sent to Your Inbox!
Did you know the CTN Dissemination Library has a news blog! Until now, you had to go to the website to see what was new – but we’ve (finally!) added a subscription option that lets you sign up to receive new posts by email!
What kind of information will you receive if you subscribe?
- Updates from Nodes and Protocols
- News from NIDA
- News from NIAAA, the Addiction Technology Transfer Center (ATTC) Network, NIH, and other federally funded initiatives
- Funding and fellowship opportunities
- New articles, presentations, and more in the CTN Library
- Upcoming events, webinars, and training (we also have an event calendar too!)
SIGN UP HERE! |
CTN Trial Progress
 Randomizations for Active Studies as of the October 17 Trial Progress Report.
CTN-0080 - Enrolled 140
CTN-0096 - Enrolled 28
CTN-0098 - Enrolled 178
CTN-0099 - Enrolled 1702
CTN-0100
Discontinuation - Enrolled 196
Retention - Enrolled 928
CTN-0101 - Enrolled 202
CTN-0107 - Enrolled 150
CTN-0108 - Enrolled 108
CTN-0109 - Enrolled 56
CTN-0110 - Enrolled 18
CTN-0116 - Enrolled 135
|
· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·
· · · · · · · · · · · · · · · · · · · · · · ·
Upcoming Events
 Northeast Node Webinar: Exploring the Intersection of Substance Use Disorders and Suicide: Recent Research and Clinical Implications
October 25, 2023 | 12-1pm ET
Zoom meeting ID: 919 7631 6490
Passcode: 870392
For more information, view the flyer.
Suicide and the opioid/opioid overdose epidemics have been major public health problems in the U.S. over the past two decades. This talk from Peter Jongho Na, MD, MPH (Yale School of Medicine) will cover recent research on the intersection of substance use disorders (opioid use disorder in particular) and suicide. The potential applications of research findings in clinical settings will also be discussed.
 CCTN Webinar: Addictions Research Meets Lived Experience: Lessons Learned, Opportunities and Challenges
October 30, 2023 | 1-2:30pm ET
Register here.
Peer support services have expanded to a wide variety of health service settings, and evaluating the impact of peer services is an important addition to the research agenda. In this webinar, the presenters and panel members will share lessons learned in conducting trials with persons with lived experience -peers-participating as an integral component of the intervention. The goal of the webinar is to assist investigators in designing future studies with peers as interventionists. The agenda includes an overview of the development of peer services in addiction treatment, a brief description of three research projects, and a panel discussion of peer supervision, self-care, scope of practice, fidelity, harm reduction approaches, and role induction for peers in research. The audience will have the opportunity to ask questions and engage in discussion with the presenters and panel members.
Presenters: Keith Humphries, Kelly Barth, Steve Shoptaw, Nabila El-Bassel, Todd Korthuis
Panel Members: Al Hasson (facilitator), Todd Korthuis, Louise Haynes, Pete Smith, Joanna Cooper
 Youth SIG Webinar: Parent-to-Parent Community Support: Helping Families Come Into Contact with Evidence-Informed Concepts and Strategies in the Context of Shared Lived Experience
November 3, 2023 | 11am-12pm ET
Youth SIG webinar Zoom link. (find complete Zoom details here)
Presented by Ken M. Carpenter, PhD, Research Scientist, Division on Substance Use Disorders, New York State Psychiatric Institute and
Director of Training, CMC:Foundation for Change.
Dr. Carpenter’s more recent community-based work has focused on developing resources that can be utilized by parent peer support networks to help bring evidence-informed concepts and skills to families impacted by substance use problems. He will present on pilot programs directed towards engaging families outside of the clinical service framework. The discussion will include lessons learned from these projects, continued efforts to grow a parent-to-parent support community, and the continued challenges that come along with supporting parent-to-parent efforts to promote evidence informed concepts and strategies in the context of community-based groups.
 CTN/ATTC Webinar: New Paths for Advancing Adolescent Substance Use Research
November 15, 2023 | 11am-12:30pm PT
1.5 CE/CME available!
Register here.
This webinar, sponsored by the Northwest & Pacific Southwest ATTCs and the Western States Node of the NIDA CTN, will provide an interactive learning experience for attendees to explore adolescent substance use and new paths for research. Presenter Niranjan Karnik, MD, PhD will review recent data trends related to the prevalence of substance use among teens, describe current treatment approaches, and talk about the pros and cons of social media and digital mental health interventions.
Niranjan S. Karnik, MD, PhD, is the director of the Great Lakes Node of the National Drug Abuse Treatment Clinical Trials Network (CTN). His research focuses on data science, technology, and community-based interventions for vulnerable populations with psychiatric and substance use disorders.
1.5 CME or CE credits available. See flyer for more information about available credit types.
· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·
· · · · · · · · · · · · · · · · · · · · · · ·
Apply for the 2024 LEAD Program!
 The Learning for Early Careers in Addiction and Diversity (LEAD) program, a NIDA-funded science education program focused on addictions research training is recruiting a new cohort of scholars. The program trains early career substance use disorder researchers from racial/ethnic minoritized groups that are underrepresented as NIH funded investigators. The program announcement includes eligibility criteria and instructions about how to submit an application for consideration.
The LEAD program uses the NIDA Clinical Trials Network (Western States Node) as a platform for training early-career investigators. This 3-year training program is based at the University of California, San Francisco (UCSF), and visiting scholars spend three summers in a 4-week intensive program at UCSF.
Find the application here.
The requirements are on the application, which include the following:
- Curriculum vitae
- Statement of research program (4 pages), including a study title, specific aims (1-page), and bibliography for a pilot study, which will be funded by LEAD.
- Quantitative and quantitative research methods experience
- Department chair support letter and three recommendation letters
· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·
· · · · · · · · · · · · · · · · · · · · · · ·
News from the Nodes
 Health Systems Node
Gwen Lapham, PhD, MPH, MSW, recently published Prevalence of Cannabis Use Disorder and Reasons for Use Among Adults in a US State Where Recreational Cannabis Use Is Legal, in JAMA Network Open.
Dr. Lapham led the CTN-0077 study and is a PROUD (CTN-0074) co-investigator and Kaiser Permanente Washington Health Research Institute (KPWHRI) assistant investigator and addictions health services researcher. She is also an assistant affiliate professor in the Department of Health Systems and Population Health, University of Washington, and assistant professor in the Kaiser Permanente Bernard J. Tyson School of Medicine. Since joining KPWHRI, she has capitalized on her prior social work and health services training to do impactful research on evidence-based primary care for unhealthy substance use, including alcohol, cannabis, and opioids. She has recently begun making strides in understanding cannabis use among primary care patients, including medical use and use among prenatal women.
Kelly Young-Wolff, PhD, MPH was recently selected to be a member of the NASEM Committee to Review the Public Health Consequences of Changes in the Cannabis Policy Landscape. Dr. Young-Wolff is leading CTN-0140 and is a licensed clinical psychologist and research scientist at the Kaiser Permanente Northern California Division of Research. She is also an Adjunct Associate Professor in the Department of Psychiatry, University of California, San Francisco; Consulting Assistant Professor at the Stanford University School of Medicine; and Professor, Kaiser Permanente Bernard J. Tyson School of Medicine. Dr. Young-Wolff’s research focuses on substance use, focusing specifically on cannabis use among pregnant persons and adolescents and on the impact of changes in local, state, and national policy.
New England Consortium Node
Sharon Levy, MD, MPH, Boston Children’s Hospitals, Chief, Division of Addiction Medicine, was promoted to Professor of Pediatrics at Harvard Medical School.
Roger Weiss, MD, Professor of Psychiatry at Harvard Medical School, and Chief of the Division of Alcohol, Drugs, and Addiction at McLean Hospital received the Founders Award from the American Academy of Addiction Psychiatry.
Gail D’Onofrio, MD, MS, Albert E. Kent Professor of Emergency Medicine, Professor of Medicine and Public Health, Yale University was elected to the National Academy of Medicine.
R. Kathryn McHugh, PhD is the recipient of the 2023 Anne M. Cataldo Awardee for Excellence in Mentoring at McLean Hospital and received the award on October 17th, 2023.
CTN-0131 Update
The NECN, the Lead Node of CTN-0131, hosted the Methadone Clinician Education and Support Training, held on 10/2, in Fitkin Auditorium on the campus of Yale School of Medicine. Physicians, Nurse Practitioners, Physician’s Assistants, and pharmacists represented all 6 participating sites.
Presenters included: David Fiellin, MD, Study Lead Investigator; Zoe Weinstein, MD, MS, Study Co-Investigator; Jef Bratberg, PharmD; Ayana Jordan, MD, PhD, Study Co-Investigator; David Frank, PhD; Brandy Robinson; Jeanette Tetrault, MD, Study Co-Investigator; and Richard Schottenfeld, MD, Study Co-Investigator
The CTN-0131 National Training took place via webinar 10/12-10/13.
New Publication
Levy S, Minegishi M, Brogna M, Subramaniam G, McCormack J, Weiss R, Weitzman ER. Comparing the Performance of WMH-CIDI-SAM in Adolescents to Diagnoses Made by Pediatric Addiction Medicine Specialists. Journal of Addiction Medicine, in press.
See also, our latest Node Newsletter. |
New York Node
(Pictured: John Rotrosen, Ned Nunes, and Jennifer McNeely, leadership of the NY Node)
The NYU Grossman School of Medicine’s Department of Psychiatry had retirement party on October 4th celebrating John Rotrosen MD and his remarkable career!
John joined NYU in 1968 as a medical student, stayed on through a research residency in psychiatry, and since, as faculty, most of that time overseeing clinical and research programs at Bellevue Hospital and the VA, with generous research funding mostly from the NIH and the VA.
A highlight of all of those years has been his team’s association with NIDA’s CTN since its inception in 2000, and especially since 2010 with the merger of two nodes, the first funded through NYU and the second, funded through RFMH/Columbia, into the current New York Node co-led by him and Ned Nunes as multiple-PIs.
As of July 1, Jennifer McNeely, MD, MS, Associate Professor in the departments of Population Health and Medicine at the NYU Grossman School of Medicine has assumed John’s role as contact PI at NYU. (pictured above: Dr. Rotrosen literally handing the baton to Dr. McNeely!)
Pacific Northwest Node
Andrew Saxon, MD (VA Puget Sound, UW Dept of Psychiatry & Behavioral Sciences), and Joseph Merrill, MD (UW Medicine), both long-time members of the CTN’s Pacific Northwest Node, were recently included in Seattle Met Magazine’s "Top Docs of 2023" feature (both in the category of Addiction Medicine).
Congratulations, Drs. Saxon and Merrill, and thank you for your continued support of the CTN and the Pacific Northwest Node!
 News from the ATTC Network
Increasing Awareness of the Transformative Potential of the ATTC Network - by the Northwest ATTC. ATTC Messenger, October 2023. Using scientific publication as a way to broaden familiarity with the ATTC Network and its work.
NIATx in New Places: Insights on Using NIATx in Prevention - by Erin Ficker and Maureen Fitzgerald (Great Lakes ATTC). ATTC|NIATx Service Improvement Blog, October 2023.
New Resource: National Substance Use and Mental Health Services Survey (N-SUMHSS) 2022: Data on Substance Use and Mental Health Treatment Facilities
The N-SUMHSS is a voluntary annual survey of all active substance use and mental health facilities in the United States, its territories, and D.C. The annual report presents findings on the key operational characteristics of substance use and mental health treatment facilities, use of pharmacotherapies, language assistance services, and suicide prevention assistance services.
For more from the Addiction Technology Transfer Center Network, visit their website at attcnetwork.org. |
· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·
· · · · · · · · · · · · · · · · · · · · · · ·
Post-Doc Position Open for Spring 2024 (University of Miami Center for HIV & Research in Mental Health [CHARM])
Directed by Drs. Daniel Feaster (MPI, CTN Florida Node Alliance), Sannisha Dale, and Viviana Horigian (Executive Director, CTN Florida Node Alliance), and housed under the University of Miami Center for HIV and Research in Mental Health (CHARM), CHANGE – Culturally-focused HIV Advancements through the Next Generation for Equity– offers a great opportunity to develop the next generation of researchers with the expertise to successfully address HIV and Mental Health disparities throughout the HIV prevention and treatment cascades using community-engaged research, implementation, and dissemination.
We are now accepting applications from interested post-doctoral candidates for Spring 2024. Candidates must:
- have their doctorate or medical degree at the time of appointment,
- be a U.S. citizen, and
- demonstrate a commitment to developing research careers to address mental and HIV inequities in Black, Latinx/e/o, and LGBTQ+ communities.
Questions? Email CHANGE-program@miami.edu. Learn more about the CHARM program here.
Download the flyer to learn more about this opportunity!
· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·
· · · · · · · · · · · · · · · · · · · · · · ·
 New in the CTN Dissemination Library
Potential Effect of Antidepressants on Remission from Cocaine Use Disorder — A Nationwide Matched Retrospective Cohort Study. Gao Z, et al. Drug & Alcohol Dependence 2023;251:110958. CTN-0114
Individual-Level Risk Prediction of Return to Use During Opioid Use Disorder Treatment. Luo SX, et al. JAMA Psychiatry 2023 (in press). CTN-0027, CTN-0030, CTN-0051
Training Opportunities to Leverage the CTN Network. Crump A. Webinar presented at the NIDA Steering Committee Meeting, September 18, 2023.
Implementation of Substance Use Screening in Rural Federally-Qualified Health Center Clinics Identified High Rates of Unhealthy Alcohol and Cannabis Use Among Adult Primary Care Patients. McNeely J, et al. Addiction Science & Clinical Practice 2023;18(1):56. CTN-0062
Identifying Patients with Opioid Use Disorder Using International Classification of Diseases (ICD) Codes: Challenges and Opportunities. Osterhage KP, et al. Addiction 2023 (in press). CTN-0102
Associations Between Stimulant Use and Return to Illicit Opioid Use Following Initiation onto Medication for Opioid Use Disorder. Foot C, et al. Addiction 2023 (in press). CTN-0051, CTN-0067
· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·
· · · · · · · · · · · · · · · · · · · · · · ·
News from NIDA
 Telehealth Supports Retention in Treatment for Opioid Use Disorder. NIDA News Release, October 18, 2023. Starting buprenorphine treatment for opioid use disorder through telehealth was associated with an increased likelihood of staying in treatment longer compared to starting treatment in a non-telehealth setting, according to a new study analyzing Medicaid data from 2019-2020 in Kentucky and Ohio. Published in JAMA Network Open, these findings add to a growing body of evidence demonstrating positive outcomes associated with the use of telemedicine for treatment of opioid use disorder.
The Power of Protective Layers: Employers Advancing Whole-Person Health. Nora's Blog, October 11, 2023. |
Upcoming Events
Webinar: The Ins and outs of Sharing Qualitative Data (University of Michigan)
October 24, 2023 | 2-3pm ET
NIDA-NIAAA Mini (Virtual) Convention: Frontiers in Addiction Research
November 7-8, 2023
NIDA Diversity Scholars Network Pre-Application Webinar
November 8, 2023 | 1:30-2:30pm ET
For more NIDA and CTN-related events, check out the Event Calendar on the CTN Dissemination Library website. |
   
|
